144 related articles for article (PubMed ID: 17122988)
21. Impact of cyclin D1 A870G polymorphism in esophageal adenocarcinoma tumorigenesis.
Izzo JG; Malhotra U; Wu TT; Ensor J; Babenko IM; Swisher SG; Correa A; Bresalier RS; Hittelman WN; Ajani JA
Semin Oncol; 2005 Dec; 32(6 Suppl 9):S11-5. PubMed ID: 16399423
[TBL] [Abstract][Full Text] [Related]
22. Diagnosis and therapy in advanced cancer of the esophagus and the gastroesophageal junction.
Lerut T; Coosemans W; Decker G; De Leyn P; Moons J; Nafteux P; Van Raemdonck D
Curr Opin Gastroenterol; 2006 Jul; 22(4):437-41. PubMed ID: 16760764
[TBL] [Abstract][Full Text] [Related]
23. The role of tumor suppressor genes in esophageal cancer.
Raja S; Godfrey TE; Luketich JD
Minerva Chir; 2002 Dec; 57(6):767-80. PubMed ID: 12592219
[TBL] [Abstract][Full Text] [Related]
24. [Prognostic and predictive factors of oesophageal carcinoma].
Blanchard P; Quero L; Hennequin C
Bull Cancer; 2009 Apr; 96(4):379-89. PubMed ID: 19357013
[TBL] [Abstract][Full Text] [Related]
25. Cyclooxygenase-2 and inducible nitric oxide synthase gene polymorphisms and risk of reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma.
Ferguson HR; Wild CP; Anderson LA; Murphy SJ; Johnston BT; Murray LJ; Watson RG; McGuigan J; Reynolds JV; Hardie LJ
Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):727-31. PubMed ID: 18349295
[TBL] [Abstract][Full Text] [Related]
26. Aneuploidy and overexpression of Ki67 and p53 as markers for neoplastic progression in Barrett's esophagus: a case-control study.
Sikkema M; Kerkhof M; Steyerberg EW; Kusters JG; van Strien PM; Looman CW; van Dekken H; Siersema PD; Kuipers EJ
Am J Gastroenterol; 2009 Nov; 104(11):2673-80. PubMed ID: 19638963
[TBL] [Abstract][Full Text] [Related]
27. Relationship between biomarker expression and allelic alteration in esophageal carcinoma.
Vegh I; Santiuste AD; Colina F; Bor L; Bermejo C; Aragón A; Morán-Jiménez MJ; Gómez-Cámara A; De Salamanca RE; Moreno-González E
J Gastroenterol Hepatol; 2007 Dec; 22(12):2303-9. PubMed ID: 18031395
[TBL] [Abstract][Full Text] [Related]
28. Genetics of gastroesophageal cancer: paradigms, paradoxes, and prognostic utility.
Robertson EV; Jankowski JA
Am J Gastroenterol; 2008 Feb; 103(2):443-9. PubMed ID: 17925001
[TBL] [Abstract][Full Text] [Related]
29. Gains and amplifications of c-myc, EGFR, and 20.q13 loci in the no dysplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus.
Rygiel AM; Milano F; Ten Kate FJ; Schaap A; Wang KK; Peppelenbosch MP; Bergman JJ; Krishnadath KK
Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1380-5. PubMed ID: 18559552
[TBL] [Abstract][Full Text] [Related]
30. Biomarkers of response to preoperative chemoradiation in esophageal cancers.
Luthra R; Luthra MG; Izzo J; Wu TT; Lopez-Alvarez E; Malhotra U; Choi IS; Zhang L; Ajani JA
Semin Oncol; 2006 Dec; 33(6 Suppl 11):S2-5. PubMed ID: 17178277
[TBL] [Abstract][Full Text] [Related]
31. Molecular genetic analysis of surveillance biopsy samples from Barrett's mucosa--significance of sampling.
Werther M; Saure C; Pahl R; Schorr F; Rüschoff J; Alles JU; Heinmöller E
Pathol Res Pract; 2008; 204(5):285-94. PubMed ID: 18337019
[TBL] [Abstract][Full Text] [Related]
32. Clinical characteristics, biologic behavior, and survival after esophagectomy are similar for adenocarcinoma of the gastroesophageal junction and the distal esophagus.
Leers JM; DeMeester SR; Chan N; Ayazi S; Oezcelik A; Abate E; Banki F; Lipham JC; Hagen JA; DeMeester TR
J Thorac Cardiovasc Surg; 2009 Sep; 138(3):594-602; discussion 601-2. PubMed ID: 19698841
[TBL] [Abstract][Full Text] [Related]
33. Gastroesophageal junction and gastroesophageal junction carcinoma : a short update.
Ekmektzoglou KA; Apostolopoulos P; Samelis G; Alexandrakis G
Acta Gastroenterol Belg; 2016; 79(4):471-479. PubMed ID: 28209106
[TBL] [Abstract][Full Text] [Related]
34. Genetic clonal diversity predicts progression to esophageal adenocarcinoma.
Maley CC; Galipeau PC; Finley JC; Wongsurawat VJ; Li X; Sanchez CA; Paulson TG; Blount PL; Risques RA; Rabinovitch PS; Reid BJ
Nat Genet; 2006 Apr; 38(4):468-73. PubMed ID: 16565718
[TBL] [Abstract][Full Text] [Related]
35. Molecular profiling and risk stratification of adenocarcinoma of the colon.
Mutch MG
J Surg Oncol; 2007 Dec; 96(8):693-703. PubMed ID: 18081153
[TBL] [Abstract][Full Text] [Related]
36. Comparative analysis of prognostic significance of molecular markers of apoptosis with clinical stage and tumor differentiation in patients with colorectal cancer: a single institute experience.
Ivanov K; Kolev N; Tonev A; Nikolova G; Krasnaliev I; Softova E; Tonchev A
Hepatogastroenterology; 2009; 56(89):94-8. PubMed ID: 19453036
[TBL] [Abstract][Full Text] [Related]
37. Molecular medicine of gastric adenocarcinomas.
Keller G; Höfler H; Becker KF
Expert Rev Mol Med; 2005 Aug; 7(17):1-13. PubMed ID: 16156904
[TBL] [Abstract][Full Text] [Related]
38. CRP genetic polymorphism is associated with lymph node metastasis in thoracic esophageal squamous cell cancer.
Motoyama S; Miura M; Hinai Y; Maruyama K; Usami S; Saito H; Minamiya Y; Satoh S; Murata K; Suzuki T; Ogawa J
Ann Surg Oncol; 2009 Sep; 16(9):2479-85. PubMed ID: 19495883
[TBL] [Abstract][Full Text] [Related]
39. Endoscopic ultrasound predicts outcomes for patients with adenocarcinoma of the gastroesophageal junction.
Barbour AP; Rizk NP; Gerdes H; Bains MS; Rusch VW; Brennan MF; Coit DG
J Am Coll Surg; 2007 Oct; 205(4):593-601. PubMed ID: 17903735
[TBL] [Abstract][Full Text] [Related]
40. New aspects of Helicobacter pylori infection involvement in gastric oncogenesis.
Kountouras J; Zavos C; Chatzopoulos D; Katsinelos P
J Surg Res; 2008 May; 146(1):149-58. PubMed ID: 17720195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
